Last reviewed · How we verify

NCT03374163

Effect Of Intravenous IntralipidTherapyon Pregnancy Outcome in Women With History of Recurrent Implantation Failure Undergoing Intracytoplasmic Sperm Injection-Embryo Transfer Cycle: A Randomized Controlled Trial

Completed Phase 2 Last updated 15 December 2017
What this trial tests

Phase 2 trial testing intralipid 20% in Infertility Due to Nonimplantation in 142 participants. Completed in 30 June 2017.

Timeline
1 January 2015
Primary endpoint
30 June 2017
30 June 2017

Quick facts

Lead sponsorKing Fahad Medical City
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment142
Start date1 January 2015
Primary completion30 June 2017
Estimated completion30 June 2017

Drugs / interventions tested

Conditions studied

Sponsor

King Fahad Medical City — full company profile →

Who can join

Adults 21 to 42, female only, with Infertility Due to Nonimplantation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the effect ofempiricintralipidinfusion therapy on pregnancy outcomes in patient withunexplained recurrentimplantation failure (RIF) undergoIntracytoplasmic sperm injection (ICSI).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Dual Role of Natural Killer Cells in Early Pregnancy: Immunopathological Implications and Therapeutic Potential in Recurrent Spontaneous Abortion and Recurrent Implantation Failure.
    Guan D, Chen Z, Zhang Y, Sun W, et al · · 2025 · cited 7× · PMID 40325291 · DOI 10.1111/cpr.70037

Verify or expand the search:

Other recruiting trials for Infertility Due to Nonimplantation

Currently open trials in the same condition.

Other King Fahad Medical City trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03374163.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing